+4,319.6%
XOM vs GSK
+1,674.3%
+2,645.3%
-62.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.0% | -1.3% | -2.6% | -3.6% |
| 7D | -3.1% | -3.1% | +0.1% | -2.2% |
| 30D | -9.4% | -0.9% | -8.5% | -9.3% |
| 3M | -2.4% | -4.2% | +1.8% | -1.7% |
| 6M | +1.3% | -1.6% | +2.9% | +1.1% |
| YTD | +37.0% | +2.6% | +34.4% | +34.1% |
| 1Y | +38.5% | +6.2% | +32.3% | +34.2% |
| 3Y | +68.4% | +55.0% | +13.4% | +43.7% |
| 5Y | +198.7% | +42.8% | +155.9% | +157.3% |
| 10Y | +189.3% | +102.1% | +87.2% | +124.3% |
| All | +4,319.6% | +1,674.3% | +2,645.3% | +2,227.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling